RNA-100-AR02

Approval Year

Substance Class	Nucleic Acid Created by `admin` on `Wed Apr 02 16:42:25 GMT 2025` Edited by `admin` on `Wed Apr 02 16:42:25 GMT 2025`
Nucleic Acid Type	mRNA VACCINE
Sequence Origin	VIRAL
Sequence Type	COMPLETE
Record UNII	2ZKG2M978D
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

RNA-100-AR02

Code

English

MRESVIA

Preferred Name

English

RNA (recombinant 5?-(m7G-(5??5?)-ppp-Gm)-capped all uridine?N1-methylpseudouridine-substituted respiratory syncytial virus pre-fusion F glycoprotein plus 5?-and 3?-untranslated flanking region-containing poly(A)-tailed messenger CX-032753), inner salt

Common Name

English

CX-032753

Code

English

Code System Code Type Description

CAS

2766353-31-3

Created by admin on Wed Apr 02 16:42:25 GMT 2025 , Edited by admin on Wed Apr 02 16:42:25 GMT 2025

PRIMARY

FDA UNII

2ZKG2M978D

Created by admin on Wed Apr 02 16:42:25 GMT 2025 , Edited by admin on Wed Apr 02 16:42:25 GMT 2025

PRIMARY

Sugar	Site Range	Site Count
D-Ribose (RNA)	1_1-1_1795	1795 / 1795

Linkage	Site Range	Site Count
Phosphate	1_2-1_1795	1794 / 1794

Related Record Type Details


					2ZKG2M978D

RNA-100-AR02

ACTIVE MOIETY

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
NUCLEOSIDE_SUBSTITUTION			U		N1-METHYLPSEUDOURIDINE	09RAD4M6WF
NUCLEOTIDE SUBSTITUTION	[1_1]	5'-TERMINUS			5'-GUANOSINE-M-RNA-CAP-1-3'-PHOSPHATE	T0HQY09X7B